In vitro anthelmintic efficacy of inhibitors of phosphoethanolamine Methyltransferases in Haemonchus contortus  by Witola, William H. et al.
lable at ScienceDirect
International Journal for Parasitology: Drugs and Drug Resistance 6 (2016) 44e53Contents lists avaiInternational Journal for Parasitology:
Drugs and Drug Resistance
journal homepage: www.elsevier .com/locate/ i jpddrIn vitro anthelmintic efﬁcacy of inhibitors of phosphoethanolamine
Methyltransferases in Haemonchus contortus
William H. Witola a, *, Kwame Matthews b, Mark McHugh b
a Department of Pathobiology, College of Veterinary Medicine, University of Illinois, Urbana-Champaign, USA
b Department of Agricultural and Environmental Sciences, Tuskegee University, Tuskegee, AL, USAa r t i c l e i n f o
Article history:
Received 28 November 2015
Received in revised form
12 January 2016
Accepted 12 January 2016
Available online 18 January 2016
Keywords:
Haemonchus contortus
Phosphoethanolamine N-methyltransferase
Phosphatidylcholine
Chemical inhibitors
Anthelmintic activity* Corresponding author. Department of Pathobio
Medicine, University of Illinois, Urbana-Champaign,
Urbana, IL 61802, USA.
E-mail address: whwit35@illinois.edu (W.H. Wito
http://dx.doi.org/10.1016/j.ijpddr.2016.01.002
2211-3207/© 2016 The Authors. Published by Elsevier
creativecommons.org/licenses/by-nc-nd/4.0/).a b s t r a c t
The essential phosphobase methylation pathway for synthesis of phosphocholine is unique to nema-
todes, protozoa and plants, and thus an attractive antiparasitic molecular target. Herein, we screened
compounds from the National Cancer Institute (Developmental Therapeutics Program Open Chemical
Repository) for speciﬁc inhibitory activity against Haemonchus contortus phosphoethanolamine meth-
yltransferases (HcPMT1 and HcPMT2), and tested candidate compounds for anthelmintic activity against
adult and third-stage larvae of H. contortus. We identiﬁed compound NSC-641296 with IC50 values of
8.3 ± 1.1 mM and 5.1 ± 1.8 mM for inhibition of the catalytic activity of HcPMT1 alone and HcPMT1/
HcPMT2 combination, respectively. Additionally we identiﬁed compound NSC-668394 with inhibitory
IC50 values of 5.9 ± 0.9 mM and 2.8 ± 0.6 mM for HcPMT1 alone and HcPMT1/HcPMT2 combination,
respectively. Of the two compounds, NSC-641296 depicted signiﬁcant anthelmintic activity against third-
stage larvae (IC50 ¼ 15 ± 2.9 mM) and adult stages (IC50 ¼ 7 ± 2.9 mM) of H. contortus, with optimal
effective in vitro concentrations being 2-fold and 4-fold, respectively, lower than its cytotoxic IC50
(29 ± 2.1 mM) in a mammalian cell line. Additionally, we identiﬁed two compounds, NSC-158011 and
NSC-323241, with low inhibitory activity against the combined activity of HcPMT1 and HcPMT2, but both
compounds did not show any anthelmintic activity against H. contortus. The identiﬁcation of NSC-641296
that speciﬁcally inhibits a unique biosynthetic pathway in H. contortus and has anthelmintic activity
against both larval and adult stages of H. contortus, provides impetus for the development of urgently
needed new efﬁcacious anthelmintics to address the prevailing problem of anthelmintic-resistant
H. contortus.
© 2016 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Haemonchus contortus is the most important parasitic nematode
of small ruminants that is responsible for substantial economic los-
ses in small ruminant productionworldwide (Cantacessi et al., 2012).
Anthelmintic drugs have been the only effective method of con-
trolling H. contortus infections, but there is now widespread parasite
resistance to most of the commercially available drugs (Mortensen
et al., 2003; Kaplan, 2004; Gilleard, 2006), thus warranting the ur-
gent need to identify novel molecular targets for developing a new
generation of efﬁcacious anthelmintics. Within the infected host,logy, College of Veterinary
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Ltd on behalf of Australian Society fH. contortus is a proliﬁc egg layer (Nikolaou and Gasser, 2006), thus
requiring active biogenesis of parasite plasma membranes in which
phospholipids, particularly phosphatidylcholine, are a major
component (Kent, 1995; Vial and Ancelin, 1998).
In the free-living nematode, Caenorhabditis elegans, a plant-like
phosphobase methylation pathway involving the three-step S-
adenosylmethionine-dependent methylation of phosphoethanol-
amine to phosphocholine for the biosynthesis of phosphatidyl-
choline, has been characterized and found to be essential for
C. elegans (Palavalli et al., 2006). The phosphobase methylation step
in C. elegans is catalyzed by two phosphoethanolamine methyl-
transferases (PMT1 and PMT2), that sequentially methylate phos-
phoethanolamine to phosphocholine (Palavalli et al., 2006; Brendza
et al., 2007). Two enzymes, HcPMT1 and HcPMT2 (similar to the
C. elegans PMT1 and 2, respectively) have been identiﬁed in
H. contortus and demonstrated to be bonaﬁde phosphoethanol-
amine methyltransferases for the S-adenosylmethionine-or Parasitology. This is an open access article under the CC BY-NC-ND license (http://
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phosphocholine (Lee et al., 2011). Because this phosphobase
methylation step does not exist in mammalian cells, it is considered
as an attractive molecular target for the establishment of effective
parasite-speciﬁc therapeutic regimens (Elabbadi et al., 1997;
McCarter, 2004; Mitreva et al., 2005).
The Plasmodium falciparum phosphoethanolamine methyl-
transferase (PfPMT) possesses a single methyltransferase domain
that methylates all three phosphobases (Pessi et al., 2004, 2005),
and has been shown to be essential for the growth and sexual
reproduction of the parasite (Witola et al., 2008; Bobenchik et al.,
2013). Speciﬁc chemical inhibitors for the P. falciparum PfPMT cat-
alytic activity have been identiﬁed and demonstrated to abrogate
parasite gametocyte development as well as parasite asexual
development (Bobenchik et al., 2013). These identiﬁed inhibitors of
PfPMT provide lead chemical entities for development of a new
generation of antimalarial drugs. Despite, the identiﬁcation of
H. contortus HcPMT1 and HcPMT2, no speciﬁc inhibitors for these
nematode enzymes have been reported. Herein, we describe the
identiﬁcation of speciﬁc inhibitors for the H. contortus phosphobase
methylation of phosphoethanolamine, and determine the in-
hibitors' in vitro anthelmintic activity against H. contortus third-
stage larvae and adult worms.
2. Materials and methods
2.1. Isolation of H. contortus worms from goat abomasum
The care and use of goats for experimental procedures in this
study was performed following the protocol approved by the Uni-
versity of Illinois at Urbana-Champaign and Tuskegee University
Institutional Animal Care and Use Committees. Naturally infected
goats with high H. contortus egg counts (>5000 eggs per gram of
fecal matter) were humanely euthanized and immediately their
abomasums were excised and live female H. contortus adult worms
(identiﬁed based on their barber's pole characteristic appearance)
were isolated from the abomasal contents by scooping with a
spatula and placed in PBS maintained at 37 C. The worms were
washed ﬁve times in PBS followed by three washes in RPMI me-
dium (pH 6.8, supplemented with 2% glucose, 500 units/ml peni-
cillin, 500 mg/ml streptomycin, 1.25 mg/ml amphotericin and 1 mM
chloramphenicol) (Rhoads and Fetterer, 1995), and ﬁnally resus-
pended in RPMI medium. For culture assays, the parasites in RPMI
medium were incubated at 37 C with 5% CO2. For RNA extraction,
the parasites were kept frozen at80 C until use. PCR analysis was
performed on genomic DNA extracted from isolated adult worms
following the procedure described by Zarlenga et al. (1994) to
conﬁrm that they were H. contortus and not Haemonchus placei.
2.2. Culture and isolation of H. contortus larvae from goat feces
H. contortus larvae were hatched and extracted from goat fecal
cultures following the method of Pe~na et al. (2002). Brieﬂy, fresh
fecal samples were collected from the rectum of goats with high
H. contortus egg counts (>5000 eggs per gram fecal matter) and
pooled. About 10 g of the pooled fecal samples were placed in
500 ml beakers and homogenized with an equal volume of
vermiculite. About 5 ml of distilled water was added to moisten the
homogenate and incubated at 21 C for 10 days. Every other day,
5 ml of distilled water was added and the homogenate mixed to
maintain the moisture content. After 10 days, the third-stage larvae
were extracted from the fecal homogenates by the Baermann
method. Brieﬂy, the homogenatewas re-suspended in about 100ml
of distilled water and applied to a funnel-assembly lined with
cheese cloth, with the funnel tip plugged. Additional water wasapplied to completely ﬁll the funnel assembly. The assembly was
left to sit at room temperature overnight to allow the larvae to
gravitate through the cheese cloth to the tip of the funnel. The ﬂow-
through in which larvae were contained was collected in 50 ml
conical tubes and let to settle at 4 C for 3 h to allow the larvae to
sediment. The larvae suspension was washed three times by aspi-
rating out the water (leaving just about 5 ml) followed by addition
of 40 ml of autoclaved distilled water (containing 500 units/ml
Penicillin G, 500 mg/ml Streptomycin, 1.25 mg/ml Amphotericin and
1 mM Chloramphenicol) and letting stand at 4 C for 2 h to sedi-
ment larvae after which the water was aspirated out leaving only
5ml. This was followed bywashing three timeswith 40ml of RPMI-
1640medium (pH 6.8, supplementedwith 2% glucose, 500 units/ml
penicillin, 500 mg/ml streptomycin, 1.25 mg/ml amphotericin and
1 mM chloramphenicol). The larvae concentration in the ﬁnal
suspension in RPMI-1640 medium was determined by applying
50 ml of the suspension on a glass slide with coverslip and counting
using a X10 objective of a light microscope. Larvae re-suspended in
medium were maintained in culture at 37 C, 5% CO2. PCR analysis
was performed on genomic DNA extracted from isolated larvae
following the procedure described by Zarlenga et al. (1994) to
conﬁrm that they were H. contortus and not H. placei.
2.3. H. contortus cDNA synthesis and analysis of HcPMT1 and
HcPMT2 expression
About 150 mg of pelleted H. contortus female adult worms were
homogenized in 1 ml of Trizol reagent using a mortar and pestle and
total RNA was extracted from the homogenate following the Trizol
reagent protocol (Life Technologies). One microgram of total RNA
was treated with DNase I (Invitrogen) to remove residual genomic
DNA and reverse transcription (RT) was performed using the iScript
Select cDNA Synthesis kit (BIO-RAD) following the kit protocol.
Quantitative real time PCR to determine transcript levels for HcPMT1
and HcPMT2 was performed using the H. contortus cDNA as tem-
plate. The HcPMT1 primer pair usedwas 50-TTCACTACTGTGCTAGCA-
30 (forward) and 50-CTTTCAATGACCACGAT-30 (reverse), while the
HcPMT2 primer pair was 50-ATGCCCTCAGGATGACCAGAGAA-30
(forward) and 50-GGATCGTAGAGCAGCAGTGATAAA-30 (reverse). The
primer pair for H. contortus b-tubulin (Genbank accession number:
EF198865) was 50-CTTGTTGATCTCGAGCCTGGAA-30 (forward) and
50-AAGGCAATCACAACCTTCAGCTT-30 (reverse). To generate quanti-
ﬁcation standards, PCR products for each primer pair were frac-
tionated on agarose gel and extracted by the QIAquick® Gel
extraction kit (Qiagen). The extracted gene fragments were quanti-
ﬁed by Nanodrop Spectrophotometer (Fisher) followed by 10-fold
serial dilution to prepare quantiﬁcation standards. Real-time PCR
mix consisted of 1 ml cDNA as template, 1 ml of primer mix (500 nM
each), and 10 ml of SsoFast EvaGreen supermix (Bio-Rad), with the
ﬁnal volume made up to 20 ml with nuclease-free water. Cycling was
performed using a CFX 96 real-time system (Bio-Rad), and transcript
quantities were derived by the system software using the generated
standard curves. The relative amounts of HcPMT1 and HcPMT2
transcripts were derived by dividing their respective concentrations
by the concentration of b-tubulin.
2.4. Cloning of HcPMT1 and HCPMT2 coding sequences
Primer pairs for ampliﬁcation of the coding sequences of
HcPMT1 and 2 were designed based on the gene sequences re-
ported by Lee et al. (2011). The primer pair for HcPMT1 coding
sequence was 50-CTCGAGATGACGGCTGAGGTGCGACGGGATT-30
(Forward, with the XhoI restriction site italicized and start codon in
bold) and 50-GGATCCTTAAAGTGAAGCCTTGATCA-30 (Reverse, with
the BamHI site italicized and stop codon in bold). The primer pair
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GATGCCTGCCGTTGAACGACAACTGATT-30 (Forward, with the XhoI
restriction site italicized and start codon in bold) and 50-
GGATCCTTATTGTGGCTTGACAGCAGCGAA-30 (Reverse, with the
BamHI site italicized and stop codon in bold). The forward and
reverse primers incorporated the XhoI and BamHI restriction se-
quences, respectively, for cloning at the XhoI/BamHI unique site of
pET15b vector (Novagen). The genes were ampliﬁed by polymerase
chain reaction from H. contortus cDNA using high ﬁdelity DNA po-
lymerase (Affymetrix) and cloned into pGEMT for sequencing to
conﬁrm identity. The genes were excised from the pGEMT vector by
dual XhoI/BamHI restriction enzyme digestion and sub-cloned at
the XhoI/BamHI site in the pET15b expression vector in-frame with
the hexahistidine (His-tag) at the N-terminal. The recombinant
vectors were propagated in DH5a E. coli and subsequently trans-
formed into protein expression E. coli BL21-CodonPlus-DE3-RIL
(Stratagene).2.5. Expression and puriﬁcation of recombinant HcPMT1 and
HcPMT2
E. coli BL21-CodonPlus-DE3-RIL strain transformed with pET15b
carrying either HcPMT1 or HcPMT2 coding sequence were cultured
at 37 C in Luria brothmedium containing 100 mg/ml ampicillin and
34 mg/ml chloramphenicol to an A600 of 0.6 and protein expression
induced by the addition of 1 mM isopropyl-b-d-thiogalactopyr-
anoside. Bacteria was harvested from the cultures by centrifugation
and resuspended in BugBuster reagent for native protein extraction
(Novagen) containing a protease inhibitor mix (Roche Diagnostics),
40 units/ml benzonase and 10 mg/ml lysozyme. The resuspended
bacteria was lysed by sonication on ice and the cleared soluble
fraction of the lysate separated by centrifugation. The His-tagged
proteins were puriﬁed from the soluble fraction by nickel-afﬁnity
chromatography according to the manufacturer's instructions
(Novagen). The eluates were dialyzed using a buffer containing
5 mM HepeseKOH (pH 7.8) and 0.5 mM DTT. The purity of the
recombinant proteins was determined by SDS/PAGE, and the pro-
tein concentration was measured by the method of Bradford using
BSA as a standard.2.6. Optimization of enzyme, substrate and co-substrate
concentrations in Methyltransferase assay
The Methyltransferase HT activity kit (ENZO) is a ﬂuorescent
assay for the determination of S-adenosyl-L-methionine-depen-
dent methyltransferase activity. It is ideal for high throughput
screening of candidate compounds that may alter the activity of S-
adenosylmethionine (SAM)-dependent methyltransferases. We
customized the Methyltransferase HT Activity kit assay for the use
of optimal HcPMT1 and HcPMT2 proteins as enzymes, SAM as the
methyl-donor, and phosphoethanolamine (PE) as the substrate. To
test the enzymatic activity of HcPMT1 and HcPMT2 using the
Methyltransferase HT Activity kit, SAMwas initially used at the kit's
recommended starting concentration of 80 mM, while PE was used
at 160 mM (twice as much as SAM). The concentration of HcPMT1
and HcPMT2 were titrated either individually or in combination to
determine the optimal concentration for catalyzing the methyl-
ation of PE following the kit's instructions. Brieﬂy, the concentrated
HcPMT1 and HcPMT2 protein solutions, SAM and PE were dilutedPercent Inhibition ¼ Mean non­inhibited reaction RFU  Mean Inð
Mean non­inhibited reactin the kit's 1X Transferase Assay buffer and added to a reaction
mixture containing 25 ml 1X Methyltransferase Reaction Buffer and
100 ml of Detection Solution, and the ﬁnal volumemade up to 150 ml
with 1X Transferase Assay buffer. The ﬁnal concentration of each of
SAM and PE in the reaction mixture was 80 mM and 160 mM,
respectively, while the ﬁnal concentration of HcPMT1 and HcPMT2
proteins varied in increment. A blank reaction mixture lacked
protein and its ﬂuorescence was used for correcting for background
ﬂuorescence in the test samples. The reactions were prepared in
triplicate wells in a black ﬂat-bottomed 96 well plate, covered with
a foil plate sealer and incubated at room temperature (24 C) with
shaking for 45 min. After 45 min of incubation, a positive reaction
mixture was prepared containing 25 ml of 1X Positive Control so-
lution, 100 ml Detection solution and 25 ml of 1X Methyltransferase
Reaction Buffer, and the plate incubated for an additional 20 min
with shaking at room temperature. Then, 50 ml of ice-cold iso-
propanol was added to each reaction mixture to stop the reaction
and the ﬂuorescence read at 380ex/520em using a Gemini XPS
Microplate ﬂuorescence reader (Molecular Devices).
To determine the optimal concentration of PE in the assay,
increasing concentrations of PE (starting at 40 mM) were used, with
the concentration of SAM maintained at 80 mM and HcPMT1 and
HcPMT2maintained at the derived optimal concentrations. Likewise,
to determine the optimal concentration of SAM in the assay,
increasing concentrations of SAM (starting at 40 mM)were used with
the concentration of PE, HcPMT1 and HcPMT2 maintained at the
derived optimal concentrations. To determine the substrate speci-
ﬁcity of HcMPT1 and HcPMT2 enzymes, ethanolamine and phos-
phatidylethanolaminewere each used in themethyltransferase assay
at 160 mMas alternative substratewith SAMas co-substrate at 80 mM.2.7. Screening chemical compounds for inhibitory activity against
HcPMT1 and HcPMT2
The chemical compoundswere obtained fromtheNational Cancer
Institute/Developmental Therapeutics Program Open Chemical Re-
pository. The compounds were reconstituted in dimethyl sulfoxide
(DMSO) as stock solutions. Just before use, aliquots of the stock so-
lutions were diluted in the Methyltransferase HT kit's 1X Transferase
Assay Buffer and added at increasing concentrations to the reaction
mix (containing 25 ml 1XMethyltransferase Reaction Buffer, 100 ml of
Detection Solution, 95mMSAM,160mMphosphoethanolamine,11mg/
ml each of HcPMT1 and HcPMT2) and the ﬁnal volume made up to
150 ml with 1X Transferase Assay buffer. Reaction mixtures without
inhibitor, but containing DMSO (equivalent to the volume of inhibitor
stock solution used in the test reactions) were set up as the non-
inhibited reactions. A blank reaction mix did not contain inhibitor
nor did it contain HcPMT1 and HcPMT2. All the reactions were pre-
pared intriplicatewells inablackﬂat-bottomed96wellplate, covered
with a foil plate sealer and incubated at room temperature (24 C)
withshaking for45min.After45minof incubation,apositive reaction
mixturewasprepared containing25ml of1XPositiveControl solution,
100 ml Detection solution and 25 ml of 1XMethyltransferase Reaction
Buffer, and the plate incubated for an additional 10minwith shaking
at room temperature (24 C). Then, 50ml of iced-cold isopropanolwas
added to each reaction to stop the reaction and the ﬂuorescence read
at 380ex/520em. The percent inhibition of each compound dilution
was calculated using the following formula:
where:hibited reaction RFUÞ  100
ion RFU
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rescence (RFU) for triplicate assays of the reaction assay without
inhibitor.
 Mean inhibited reaction RFU is the average RFU for triplicate
assays of the reaction assay with inhibitor.
The IC50 values for the inhibitory activity of the compounds
were derived using nonlinear regression analysis by Graph pad
Prism software version 6.0 program.
2.8. Chemical compound cytotoxicity assay
To determine the cytotoxic concentrations of the candidate
compounds in mammalian cells, a colorimetric assay using the cell
proliferation reagent WST-1 (Roche) for the quantiﬁcation of cell
viability was performed on MonoMac6 cells (Ziegler-Heitbrock
et al., 1988). MonoMac6 cells were seeded at 104/well in RPMI-
1640 medium (without red phenol) supplemented with 10% fetal
calf serum, 2.05 mM L-glutamine, 1  nonessential amino acids
(Sigma), OPI medium supplement (Hybri Max; Sigma), and 1%
penicillin-streptomycin in 96 well plates. Each candidate com-
pound was added to triplicate wells at increasing concentrations.
Control wells without chemical compound, but towhich equivalent
volumes of DMSO (chemical compound solvent) was added were
also set up. After 48 h of culture at 37 C, with 5% CO2, a colorimetric
assay using the cell proliferation reagent WST-1 (Roche) for the
quantiﬁcation of cell viability was performed on the cultures by
adding 20 ml of the WST-1 reagent to each well. After mixing, the
plates were wrapped in aluminum foil and incubated for 1 h at
37 C with 5% CO2. After 1 h of incubation, 150 ml of the medium
from each well was transferred to a new 96-well plate and quan-
tiﬁcation of the formazan dye produced by metabolically active
cells was read as absorbance at a wavelength of 420 nm using a
scanning multi-well spectrophotometer (Spectra Max 250; Mo-
lecular Devices).
2.9. Analysis of the anthelmintic effect of chemical compounds
One hundred adult H. contortus female worms (freshly isolated
from the abomasum of goat) or 100 H. contortus third-stage (L3)
larvae (freshly isolated from fecal cultures) were resuspended in
20 ml of supplemented RPMI-1640 medium (containing 500 units/
ml Penicillin G, 500 mg/ml Streptomycin, 1.25 mg/ml Amphotericin
and 1 mM Chloramphenicol) in petri dishes in triplicate with or
without increasing concentrations of candidate chemical com-
pound, and incubated at 37 C with 5% CO2 for 36 h. To control
cultures without chemical compound, equivalent volumes of DMSO
(chemical compound solvent) was added. Additionally, control
cultures without DMSO nor compound were included. After 36 h of
culture, the petri dishes were placed under bright ﬂuorescent light
for 5min on a heat padmaintained at 37 C to stimulate theworms,
and then 50 worms in each dish were randomly counted using a
dissection light microscope. Of the 50 worms counted, the per-
centages of very sinuously motile, sluggishly motile (intermittent
jerkymovements) and immotile wormswere determined. Based on
the percentage of the non-motile parasites at each concentration of
the compound tested, the IC50 of the compound was derived using
nonlinear regression analysis by Graph pad Prism software version
6.0 program.
2.10. Statistical analysis
Statistical analyses were performed by analysis of variance
(ANOVA) using the GLM Procedure of SAS (SAS Institute, Cary, NC)
and the signiﬁcance level was set at P < 0.05.3. Results
3.1. Expression analysis and cloning of HcPMT1 and HcPMT2
The HcPMT1 coding sequence we ampliﬁed from H. contortus
cDNA was found to be 1050 bp, which when aligned with the
HcPMT1 sequence reported by Lee et al. (2011), lacked a 333 bp
fragment positioned at 859 bp to 1192 bp of the coding sequence
reported by Lee et al. (2011) (Fig. 1), suggesting that the extra 333
bp fragment in the sequence of Lee et al. (2011) could be an intron.
Despite the difference, alignment of the amino acids sequences
showed that the two genes coded for proteins encompassing an
identical N-terminal methyltransferase domain, indicating that
they both would retain their functionality. The sequence we
ampliﬁed and cloned for HcPMT2 was identical to that reported by
Lee et al. (2011). Using the H. contortus cDNA, we performed
quantitative real time PCR to determine the expression levels of
HcPMT1 and HcPMT2 normalized to H. contortus b-tubulin.
HcPMT1 transcripts were 1.2-fold higher than HcPMT2 transcripts,
but there was no signiﬁcant (P < 0.05) between the two.3.2. HcPMT1 and HcPMT2 catalyze the SAM-dependent
methylation of phosphoethanolamine
To analyze the activity of HcPMT1 and HcPMT2 proteins in
catalyzing the SAM-dependent trans-methylation of phosphoe-
thanolamine (PE) using the Methyltransferase HT Activity kit assay
(ENZO), HcPMT1 and HcPMT2were expressed and puriﬁed natively
(Fig. 2) and used in the assay as enzymes. First, we tested the in-
dividual proteins' catalytic activity at varying concentrations and
found that HcPMT1 alone depicted a concentration-dependent
increase in catalytic activity while HcPMT2 on its own did not
show any signiﬁcant catalytic activity at all the concentrations
tested. However, when HcPMT1 and HcPMT2 were combined the
catalytic activity was signiﬁcantly higher (P < 0.05) than that of
HcPMT1 alone in a concentration-dependent manner (Fig. 3).
During the SAM-dependent methylation of PE, HcPMT1 catalyzes
the ﬁrst step leading to the formation of phosphomonomethyle-
thanolamine (PMME) and the release of S-adenosylhomocysteine
(SAH) (Lee et al., 2011). The SAH activates the ﬂuorophore in the
kit's detection solution leading to detectable ﬂuorescence. HcPMT2
catalyzes the methylation of PMME to phosphodimethylethanol-
amine (PDME) and subsequent methylation of PDME to phos-
phocholine, releasing SAH at each methylation step. This is
consistent with the observed lack of catalytic activity when
HcPMT2 is used as the sole enzyme in the assay because the only
substrate in the reactionmixturewas PEwhich is not a substrate for
HcPMT2. On the other hand, when HcPMT1 is used alone it's able to
methylate PE, with the activity increasing signiﬁcantly when both
HcPMT1 and HcPMT2 are added to the assay because this results in
the generation of PMME which is a substrate for HcPMT2. The
optimal concentration of HcPMT1 was found to be about 11 mg/ml
(Fig. 3A). Similarly when HcPMT1 and HcPMT2 were used in
combination, the optimal concentration of each protein in the assay
was about 11 mg/ml and this was the concentration that was used in
the subsequent assays. Titration of the concentration of PE and SAM
depicted optimal concentrations of 160 mM and 95 mM, respectively
(Fig. 3B and C) and these were the concentrations that were used in
the subsequent assays. To determine the substrate speciﬁcity of
combined activity of HcPMT1 and HcPMT2, ethanolamine or
phosphatidylethanolamine were used as substrate with SAM as co-
substrate. At all concentrations tested, there was no notable sig-
niﬁcant methylation activity for both ethanolamine and phospha-
tidylethanolamine (data not shown).
Fig. 1. Alignment of H. contortus HcPMT1 coding sequence cloned in the present study (WW) with the sequence reported by Lee et al. (2011) (LS). The region indicated by dashed
line (—) illustrates the sequence fragment that is present in the LS but absent in the WW coding sequence.
Fig. 2. Sodium dodecyl sulfate polyacrylamide gel electrophoresis analysis of afﬁnity
column chromatography-puriﬁed recombinant His-tagged HcPMT1 and HcPMT2
proteins. HcPMT1 and HcPMT2 were expressed as 41 kDa and 52 kDa recombinant
proteins, respectively.
W.H. Witola et al. / International Journal for Parasitology: Drugs and Drug Resistance 6 (2016) 44e53483.3. Analysis of compounds' inhibitory effect on catalytic activity of
HcPMT1 and HcPMT2
To identify chemical compounds that have inhibitory activity
against the methyltransferase activity of HcPMT1 and HcPMT2, we
obtained 28 chemical compounds (Table 1) from the National
Cancer Institute Open Chemical Repository that we had previously
tested for inhibitory activity against the P. falciparum phosphoe-
thanolamine methyltransferase (PfPMT) (Bobenchik et al., 2013).
Among these 28 compounds we found two compounds, NSC-
641296 and NSC-668394, that inhibited the catalytic activity of
HcPMT1 as the sole enzyme and the combination of HcPMT1 and
HcPMT2 in a concentration-dependent manner (Fig. 4A and B). The
inhibitory effects of NSC-641296 and NSC-668394 against the
combination of HcPMT1 and HcPMT2 were signiﬁcantly (P < 0.05)
higher than that of HcPMT1 as the sole enzyme at all concentra-
tions tested suggesting that these two compounds were inhibiting
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Fig. 3. (A) Titration of HcPMT1 only (dotted line), HcPMT2 only (dashed line) and HcPMT1 þ HcPMT2 (solid line) in the methyltransferase assay with S-adenosylmethionine and
phosphoethanolamine each maintained at 80 mM and 160 mM, respectively. When HcPMT1 and HcPMT2 were used in combination, each was added at the depicted concentration.
(B) Titration of phosphoethanolamine concentration in the methyltransferase assay with S-adenosylmethionine maintained at 80 mM and each of HcPMT1 and HcPMT2 maintained
at 11 mg/ml in the reaction mixtures. (C) Titration of S-adenosylmethionine with phosphoethanolamine maintained at 160 mM and each of HcPMT1 and HcPMT2 maintained at
11 mg/ml in the reaction mixtures. The data shown represent means of three independent experiments with standard error bars.
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641296's IC50 values were 8.3 ± 1.1 mM and 5.1 ± 1.8 mM for inhi-
bition of the catalytic activity of HcPMT1 alone and HcPMT1/
HcPMT2 combination, respectively (Table 2). NSC-668394's inhib-
itory IC50 values were 5.9 ± 0.9 mM and 2.8 ± 0.6 mM for HcPMT1
alone and HcPMT1/HcPMT2 combination, respectively (Table 2).
Compounds NSC-158011 and NSC-323241 were observed to have
modest inhibitory effect against the catalytic activity of the com-
bination of HcPMT1 and HcPMT2 and did not have any signiﬁcant
inhibitory effect against the activity of HcPMT1 as the sole enzyme
(Fig. 4C and D), suggesting that they only inhibited the activity of
HcPMT2. Compound NSC-158011 inhibited the combined activity
of HcPMT1 and HcPMT2 to a maximum of 12% at a concentration of
about 15 mM (Fig. 4C), while the maximum inhibition rate (21%) for
compound NSC-323241 was attained at a concentration of 12 mM
(Fig. 4D). DMSO only at all volumes used did not affect the catalytic
activity of the enzymatic assays without inhibitors (data not
shown).
3.4. Anthelmintic effect of compounds with inhibitory effect against
HcPMT1 and HcPMT2
To determine the anthelmintic effect of the chemical com-
pounds that had inhibitory effect against the catalytic activity of
HcPMT1 and HcPMT2, we cultured H. contortus adult femaleworms
and third-stage larval worms in the presence or absence ofincreasing concentrations of compounds NSC-641296, NSC-
668394, NSC-158011 and NSC-323241. After 36 h of culture, a total
of 50 worms per culture were randomly counted to establish the
percentage of worms that were actively sinuously motile, slug-
gishly motile or non-motile. For all compound assays, analysis of
worm counts in the control cultures with or without increasing
concentrations of DMSO showed that DMSO (up to the highest
amount used in the assays) had no effect on the motility of the
worms.
In our preliminary work, we had observed that the effect of
compound NSC-641296 on motility of H. contortus was notable as
early as 24 h of culture, and becamemore evident at 36 h of culture.
Therefore, considering that culture of H. contortus is transient, with
the associated risk of fungi and bacteria proliferation if cultures are
maintained for a long time, we chose to analyze the assays at the
earliest time point (36 h of culture) when the effect of the com-
pound NSC-641296 was prominently evident. In larval cultures
treated with compound NSC-641296, there was a compound
concentration-dependent reduction in larval motility when
compared to the untreated larvae. As shown in Fig. 5, a signiﬁcant
(P < 0.05) decrease in the percentage of very motile larvae and a
corresponding signiﬁcant (P < 0.05) increase in sluggishly motile
larvae was observed starting at 4 mM of NSC-641296 in medium.
Above 4 mM of NSC-641296, the percentage of sluggishly motile
larvaewas at least 2.7-fold signiﬁcantly (P < 0.001) higher than that
of very motile worms. From 14 mM and above of NSC-641296, the
Table 1
Chemical compounds screened for inhibitory activity against the catalytic activity of HcPMT1 and HcPMT1 based on the list of compounds reported by Bobenchik et al. (2013).
NSC# Chemical formula Chemical name
7346 C10H12CuN2O8.2Na Cuprate(2-), [[N,N0-1,2-ethanediylbis[N-(carboxymethyl)glycinato]](4-)-N,N0 ,O,O0 ,ON,ON0]-, disodium, (OC-6-21)
22225 C9H4Cl6O4.Cd 1,2,3,4,7,7-hexachlorobicyclo[2.2.1]hept-2-ene-5,6-dicarboxylic acid
24048 C21H18N2O.HI ND
37031 C20H14N2O7S2 ND
39225 C12H20N2O2 1,2-Benzenediol,3,5-bis[(dimethylamino)methyl]
46613 C13H13N5 ND
47924 C18H17NO2 ND
57998 C13H19NS.C7H4ClNO3 ND
85459 C16H24N2O4 3,6-Bis(morpholinomethyl)pyrocatechol
88947 C17H13NO8S2.Na ND
109268 C32H36Cl2Cu2N2O2 Copper, di.mu.-chloribis[1-[(1-piperdinyl-.kappa.N)methyl]-2-naphthalenolato-.kappa.O]di-
113997 C14H10O4S2 ND
125034 C18H12N2O2S2 2,20-disulfanediyldiquinolin-8-ol
150080 C12H17N3O3 2-(1,3-dimethylhexahydropyrimidin-2-yl)-4-nitrophenol
158011 C18H15NS2 N-naphthalen-1-yl-2-phenylsulfanylethanethioamid
169942 C16H28Cu2N8O8 ND
173904 C24H29ClN2O4 Carbamic acid, [1-[[[3-chloro-2-oxo-1-(phenylmethyl)propyl]amino]carbonyl]-3-methylbutyl]-, phenylmethyl ester
175493 C9H11FeNOS2 Iron, carbonyl(.eta.(5)-2,4-cyclopentadien-1-yl) (dimethylcarbamodithioato-S,S0)-
310551 C18H20CuN6S4 Copper; [(6-methylpyridin-2-yl)methylideneamino]-(methylsulfanylsulfoniumylidenemethyl)azanide
323241 C16H22N4Se 3-Azabicyclo[3.2.2]nonane-3-carboselenoic acid, [1-(2-pyridinyl)ethylidene]hydrazide
348401 C11H6N8O3S 4-(6-Thioguanine)-7-nitro-2,1,3-benzoxadiazole
371777 C15H14N2O4S ND
622648 C8H13N2S3.ClO4 ND
632233 C16H15NO2S ND
638646 C26H24Cl4N2O3.ClH 4-Piperidinone, 3,5-bis[(3,4-dichlorophenyl)methylene]- 1-[3-(4-morpholinyl)-1-oxopropyl]-, monohydrochloride
641296 C13H19ClCuN4S Hydrazinecarbothioamide, N,N-dipropyl- 2-(2-pyridinemethylene)-, (N,N,S)-copper(II) chloride complex, (SP-4-3)-
668394 C17H12Br2N2O3 5,8-Quinolinedione, 7-[[2-(3,5-dibromo-4-hydroxyphenyl)ethyl]amino]-
ND, not derived.
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Fig. 4. Percent inhibitory effect of varying concentrations of NSC-641296 (A), NSC-668394 (B), NSC-158011 (C) and NSC-323241 (D) chemical compounds on the catalytic activity of
HcPMT1 þ HcPMT2 combination (solid line) or HcPMT1 only (dashed line) proteins in the methyltransferase assay. The data shown represent means of three independent ex-
periments with standard error bars.
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cantly (P < 0.001) higher than that of very motile worms.Additionally, at 22 mM of NSC-641296, the percentage of immotile
worms was 4-fold signiﬁcantly (P < 0.001) higher than the
Table 2
Chemical compounds' IC50 values for inhibition of catalytic activity of HcPMT1 only and HcPMT1 þ HcPMT2 combination.
Compound HcPMT1 Activity inhibition IC50 (mM) HcPMT1 þ HcPMT2 Activity inhibition IC50 (mM)
NSC-641296 8.3 ± 1.1 5.1 ± 1.8
NSC-668394 5.9 ± 0.9 2.8 ± 0.6
NSC-158011 ND* ND*
NSC-323241 ND* ND*
ND* ¼ not derivable because of low inhibitory activity.
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Fig. 5. Analysis of the effect of varying concentrations of chemical compound NSC-641296 on the motile activity of H. contortus third-stage larvae after 36 h of culture in sup-
plemented RPMI-1640 medium. For each culture, 50 larvae were counted and the percentage of very motile larvae (hatched columns), sluggishly motile larvae (white columns) and
non-motile larvae (gray columns) determined. The data shown represent means of three independent experiments with standard error bars. Arrow-heads indicate the column data
that is different with the level of signiﬁcance denoted by asterisks (*P < 0.05; * *P < 0.001).
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
0 2 4 6 8 10
M
ea
n 
%
 W
or
m
s 
NSC-641296 (μM) 
* * 
*
  * * 
Fig. 6. Analysis of the effect of varying concentrations of chemical compound NSC-
641296 on the motile activity of adult female H. contortus worms after 36 h of cul-
ture in supplemented RPMI-1640 medium. For each culture, 50 worms were counted
and the percentage of motile worms (dark columns) and non-motile worms (white
columns) determined. The data shown represent means of three independent exper-
iments with standard error bars. Arrow-heads indicate the column data that is
different with the level of signiﬁcance denoted by asterisks (*P < 0.05; * *P < 0.001).
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motile worms decreased signiﬁcantly (P < 0.001), while the num-
ber of sluggishly motile and non-motile larvae increased signiﬁ-
cantly (P < 0.001) in a dose-dependent format (Fig. 5), indicating
that the compound had anthelmintic activity against H. contortus
larvae. Likewise, in cultures of adult worms treated with compound
NSC-641296, after 36 h there was a signiﬁcant (P < 0.05) reduction
in the percentage of motile worms and a corresponding signiﬁcant
(P < 0.001) increase in the number of immotile worms, starting at
4 mM of NSC-641296 in medium (Fig. 6). At 8 mM and above, the
percentage of immotile worms was at least 2-fold signiﬁcantly
(P < 0.001) higher than that of motile worms (Fig. 6). Overall, there
was a signiﬁcant (P < 0.001) compound dose-dependent reduction
in the percentage of motile worms, with a corresponding signiﬁ-
cant (P < 0.001) increase in the percentage of non-motile worms
(Fig. 6) suggesting that the compound had anthelmintic activity
against the adult worms as well. Coincidentally, the number of
motile worms in the NSC-641296-treated cultures was observed to
decrease by half at a concentration of NSC-641296 (8 mM) that
depicted the highest inhibitory effect against the catalytic activity
of HcPMT1 and HcPMT2. By non-linear regression analysis, we
derived the IC50 of NSC-641296 to be about 7 ± 1.8 mM and
15 ± 2.9 mM against adult worms and larval worms, respectively.
Analysis of the toxic concentrations of compound NSC-641296 in
mammalian monocytic cells showed that its cytotoxic IC50 was
29 ± 2.1 mM, which was 4-fold and 2-fold higher than its anthel-
mintic IC50 against adult worms and larvae, respectively.
Compound NSC-668394, that also signiﬁcantly inhibited the
catalytic activity of HcPMT1 and HcPMT2, did not show anysigniﬁcant anthelmintic effect against both larvae and adult
H. contortus (data not shown) even at a concentration (60 mM) that
was 12-fold higher than the concentration (5 mM) at which it was
Fig. 7. Illustrations of the chemical structures of compounds 641296 (A) and 668394
(B).
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HcPMT2 activity. Compounds NSC-158011 and NSC-323241 that
had comparatively lower inhibitory effect against HcPMT1 and
HcPMT2 activity also did not show any anthelmintic effect against
either the adult worms or the larvae at all the concentrations tested
up to a maximum of 80 mM (data not shown).
4. Discussion
Small ruminants, despite their resilience are known to be highly
susceptible to the stomach worm, H. contortus (Soulsby, 1982). The
control of H. contortus relies heavily on the use of anthelmintic
drugs, but multi-drug resistant populations of H. contortus are now
widespread and pose a major threat to the small ruminant industry
worldwide (Kaplan, 2004; Sargison et al., 2007). Thus, there is ur-
gent need to identify, characterize and validate novel molecular
drug targets as well as to identify their speciﬁc chemical inhibitors
in H. contortus for developing a new generation of effective drugs
against H. contortus and other helminths.
The phosphobase methylation pathway for the biosynthesis of
phosphatidylcholine is unique to nematodes, plants and some
apicomplexan protozoa (McCarter, 2004; Mitreva et al., 2005),
making it an ideal molecular target for developing new anthel-
mintic agents. Herein, we screened chemical compounds with the
goal of identifying those with inhibitory activity against enzymes
catalyzing the phosphobase methylation step in H. contortus.
To screen the chemical compounds, we utilized the commer-
cially available Methyltransferase HT Activity Assay kit (ENZO) in
which we used natively puriﬁed HcPMT1 and HcPMT2 recombi-
nant proteins as the methyltransferase enzymes. When HcPMT2
was used alone as the enzyme, there was no notable catalytic ac-
tivity, while HcPMT1 alone depicted signiﬁcant catalytic activity
that was augmented by combining HcPMT1 and HcPMT2 as en-
zymes in the assay. Unlike P. falciparum which possesses a single
methyltransferase that catalyzes all three steps of methylation of
phosphoethanolamine (Pessi et al., 2004), H. contortus possesses
two enzymes, HcPMT1 and HcPMT2, that sequentially methylate
phosphoethanolamine (PE) to phosphocholine (Lee et al., 2011).
HcPMT1 possesses an N-terminal methyltransferase domain that
catalyzes the ﬁrst step of methylating PE to phosphomonomethy-
lethanolamine (PMME). On the other hand, HcPMT2 possesses the
C-terminal domain that functions to catalyze the subsequent two
methylation steps of converting PMME to phosphodimethyletha-
nolamine (PDME) and methylating PDME to phosphocholine
(Brendza et al., 2007; Lee and Jez, 2013). This is consistent with the
observation that HcPMT2 could not catalyze the methylation of PE
while HcPMT1 did, leading to the generation of PMME, a substrate
for HcPMT2 resulting in increased detectable ﬂuorescence due to
increased generation of S-adenosylhomocysteine. This in-concert
catalytic activity of HcPMT1 and HcPMT2 for synthesis of phos-
phocholine provides two potential drug targets in the phosphobase
methylation pathway of H. contortus. Interestingly, we observed
that HcPMT1 and HcPMT2 expression levels in H. contortus are
similar, consistent with their in-concert catalytic activity.
Among the chemical compounds tested, NSC-641296 and NSC-
668394 that signiﬁcantly inhibited the activity of HcPMT1 as a
sole enzyme also more effectively inhibited the combined activity
of HcPMT1 and HcPMT2 than compounds NSC-158011 and NSC-
323241 that did not inhibit HcPMT1 as a sole enzyme. Interest-
ingly, in previous studies, both NSC-158011 and NSC-323241 were
found to have signiﬁcant inhibitory effect against the catalytic ac-
tivity of the P. falciparum PMT comparable to the inhibitory activ-
ities of NSC-641296 and NSC-668394 (Bobenchik et al., 2013).
Unlike H. contortus which has two PMT enzymes, P. falciparum
possesses a single multifunctional PMT enzyme that contains asingle methyltransferase domain responsible for all three methyl-
ation steps (Lee and Jez, 2013). The P. falciparum enzyme is more
closely related to H. contortus HcPMT2 in structure of the catalytic
domain (Lee and Jez, 2014). This is consistent with our observation
that compounds NSC-158011 and NSC-323241 that have been
shown to signiﬁcantly inhibit the activity of the P. falciparum PMT
had no inhibitory effect against H. contortus HcPMT1 which initi-
ates the methylation of PE.
When tested for anthelmintic activity against H. contortus adult
and larval worms, only compound NSC-641296 had potent anti-
parasitic activity. It was, however, surprising that NSC-668394,
which had inhibitory effect against HcPMT1 and HcPMT2 en-
zymes comparable to that of NSC-641296, did not show any
anthelmintic activity against H. contortus adult or larval worms.
This can possibly be attributed to differences in uptake of the
compounds by the worm cells because the chemical structures of
the two compounds are signiﬁcantly different (Fig. 7). Despite the
notable anthelmintic effect of NSC-641296 against third-stage
larvae and adult H. contortus, with IC50 values of 15 ± 2.9 mM and
7 ± 2.9 mM, respectively, when compared to its cytotoxic IC50
(29 ± 2.1 mM) in a mammalian cell line, it is evident that this
compound has low selectivity which would impact its usefulness.
Therefore, although the targeted pathway is nematode-speciﬁc,
this fact alone cannot be used as a strong argument for the ability
to readily develop nematode-speciﬁc drugs. Nevertheless, chemical
structure modiﬁcations to optimize compound solubility, stability,
cellular uptake and inhibitory activity can potentially enhance the
anthelmintic activity, while reducing the level of toxicity to
mammalian cells for NSC-641296 (Fig. 7A) and possibly that of NSC-
668394 (Fig. 7B). NSC-158011 and NSC-323241 that have both been
reported to have signiﬁcant antiparasitic activity against
P. falciparum (Bobenchik et al., 2013) did not show any anthelmintic
activity against H. contortus, consistent with their modest inhibi-
tory effect on the combined catalytic activity of HcPMT1 and
HcPMT2.
NSC-641296 depicted more potent activity against adult
H. contortus worms than against the larvae. Unlike adult
H. contortus worms, third-stage larvae are protected by a sheath
that prevents them from feeding (Cantacessi et al., 2012) and this
may make them accumulate less of the chemical inhibitor than the
adult worms would. Despite the presence of the alternative Ken-
nedy pathway that utilizes choline as a precursor for the
W.H. Witola et al. / International Journal for Parasitology: Drugs and Drug Resistance 6 (2016) 44e53 53biosynthesis of phosphatidylcholine in nematodes, our ﬁndings
here indicate that inhibition of the phosphobase pathway by
chemical compounds cannot be compensated for by the alternative
Kennedy pathway. With the prevailing populations of H. contortus
that are resistant to multiple anthelmintics, the identiﬁcation of
chemical compounds that inhibit unique essential biosynthetic
pathways in H. contortus provides impetus to the development of a
new generation of efﬁcacious anthelmintic drugs.
In parasitic nematodes, resistance to some anthelmintics has
been associated with mutations in genes encoding the drugs' mo-
lecular targets (Kwa et al., 1994; Ashraf et al., 2015). Inhibitors of
phosphoethanolamine methyltransferases have been shown to
bind the catalytic site of the enzymes to block the substrate/co-
substrate binding (Lee et al., 2012). The catalytic domains of
phosphoethanolamine methyltransferases are conserved (Lee and
Jez, 2013) and mutations in the domains lead to loss of function
(Reynolds et al., 2008) which can be detrimental to the survival of
the parasite. This may reduce the likelihood of resistance to drugs
that inhibit the phosphobase pathway arising throughmutations in
the genes encoding the methyltransferases.
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